Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Dianthus Therapeutics (DNTH) Other financing activities (2018 - 2024)

Historic Other financing activities for Dianthus Therapeutics (DNTH) over the last 3 years, with Q2 2024 value amounting to $2.2 million.

  • Dianthus Therapeutics' Other financing activities changed N/A to $2.2 million in Q2 2024 from the same period last year, while for Mar 2025 it was $2.2 million, marking a year-over-year decrease of 8194.33%. This contributed to the annual value of $14.7 million for FY2024, which is N/A changed from last year.
  • Dianthus Therapeutics' Other financing activities amounted to $2.2 million in Q2 2024.
  • Dianthus Therapeutics' 5-year Other financing activities high stood at $12.4 million for Q1 2024, and its period low was $2.2 million during Q2 2024.